 Christina Sul
Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonia, Staphylococcal | 2 | 2025 | 27 | 1.630 |
Why?
| | Superoxide Dismutase | 4 | 2025 | 301 | 1.320 |
Why?
| | Staphylococcus aureus | 3 | 2025 | 460 | 0.920 |
Why?
| | Acute Lung Injury | 3 | 2023 | 303 | 0.910 |
Why?
| | Influenza A virus | 1 | 2024 | 113 | 0.790 |
Why?
| | Blood Platelets | 3 | 2026 | 400 | 0.780 |
Why?
| | Cell Communication | 1 | 2025 | 324 | 0.770 |
Why?
| | Coinfection | 1 | 2024 | 141 | 0.750 |
Why?
| | Interleukin-10 | 1 | 2024 | 310 | 0.730 |
Why?
| | Interferon-gamma | 1 | 2024 | 784 | 0.660 |
Why?
| | Staphylococcal Infections | 1 | 2024 | 390 | 0.610 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 249 | 0.610 |
Why?
| | Neutrophils | 1 | 2025 | 1134 | 0.590 |
Why?
| | Hypoxia | 4 | 2026 | 1199 | 0.520 |
Why?
| | Platelet Activation | 3 | 2026 | 104 | 0.500 |
Why?
| | Hypertension, Pulmonary | 4 | 2026 | 1980 | 0.330 |
Why?
| | Mice | 9 | 2026 | 18365 | 0.280 |
Why?
| | Lung | 7 | 2026 | 4109 | 0.270 |
Why?
| | Vascular Remodeling | 2 | 2026 | 205 | 0.240 |
Why?
| | Receptors, Interferon | 1 | 2026 | 60 | 0.240 |
Why?
| | Neutrophil Infiltration | 1 | 2025 | 104 | 0.220 |
Why?
| | Macrophages, Alveolar | 2 | 2024 | 368 | 0.210 |
Why?
| | Orthomyxoviridae Infections | 1 | 2024 | 72 | 0.200 |
Why?
| | Animals | 9 | 2026 | 38109 | 0.200 |
Why?
| | Hyaluronic Acid | 1 | 2025 | 208 | 0.190 |
Why?
| | Macrophages | 2 | 2025 | 1511 | 0.160 |
Why?
| | Mice, Transgenic | 1 | 2025 | 2185 | 0.150 |
Why?
| | Inflammation | 4 | 2025 | 2880 | 0.150 |
Why?
| | Mice, Inbred C57BL | 3 | 2025 | 5997 | 0.150 |
Why?
| | Down Syndrome | 1 | 2026 | 534 | 0.150 |
Why?
| | Influenza, Human | 1 | 2024 | 617 | 0.140 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2024 | 2147 | 0.120 |
Why?
| | Pneumonia | 1 | 2022 | 631 | 0.120 |
Why?
| | MicroRNAs | 1 | 2022 | 701 | 0.120 |
Why?
| | Extracellular Matrix | 2 | 2025 | 553 | 0.080 |
Why?
| | Mice, Knockout | 2 | 2025 | 3125 | 0.070 |
Why?
| | Humans | 7 | 2026 | 144957 | 0.070 |
Why?
| | Platelet Factor 4 | 1 | 2025 | 36 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2026 | 4569 | 0.050 |
Why?
| | Cellular Reprogramming | 1 | 2024 | 103 | 0.050 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2025 | 266 | 0.050 |
Why?
| | Phosphofructokinase-2 | 1 | 2022 | 16 | 0.050 |
Why?
| | Alveolar Epithelial Cells | 1 | 2023 | 120 | 0.050 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2025 | 452 | 0.050 |
Why?
| | Lactic Acid | 1 | 2023 | 302 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 298 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2023 | 863 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2023 | 475 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2025 | 1339 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1890 | 0.030 |
Why?
| | Critical Illness | 1 | 2022 | 892 | 0.030 |
Why?
| | Cytokines | 1 | 2023 | 2065 | 0.030 |
Why?
| | Child | 2 | 2026 | 22657 | 0.030 |
Why?
| | Male | 3 | 2026 | 72406 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 5965 | 0.020 |
Why?
| | Biomarkers | 1 | 2022 | 4275 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 7997 | 0.020 |
Why?
| | Adult | 1 | 2026 | 40506 | 0.010 |
Why?
| | Female | 1 | 2026 | 78376 | 0.010 |
Why?
|
|
Sul's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|